Annual report pursuant to Section 13 and 15(d)

Restatement of Previously Filed Balance Sheet (Tables)

v3.22.1
Restatement of Previously Filed Balance Sheet (Tables)
12 Months Ended
Dec. 31, 2021
Restatement of Previously Filed Balance Sheet  
Summarize the effect of the revision to the Post-IPO Balance Sheet

    

As Previously

    

    

As of February 2, 2021

Reported

Adjustment

As Restated

Total assets

$

289,785,365

$

$

289,785,365

Derivative warrant liabilities

 

 

10,638,000

 

10,638,000

Total liabilities

$

10,704,851

$

10,638,000

$

21,342,851

Class A ordinary shares subject to possible redemption

 

274,080,510

 

13,419,490

 

287,500,000

Preferred shares

 

 

 

Class A ordinary shares

 

214

 

(134)

 

80

Class B ordinary shares

 

719

 

 

719

Additional paid-in capital

 

5,030,402

 

(5,030,402)

 

Accumulated deficit

 

(31,331)

 

(19,026,954)

 

(19,058,285)

Total shareholders’ equity (deficit)

$

5,000,004

$

(24,057,490)

 

(19,057,486)

Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit)

$

289,785,365

$

$

289,785,365